Definitive Healthcare (NASDAQ:DH) Trading Down 5.4% - Here's Why

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) shares fell 5.4% during mid-day trading on Friday . The stock traded as low as $3.99 and last traded at $3.97. 87,938 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 802,908 shares. The stock had previously closed at $4.19.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on DH. Wall Street Zen upgraded shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. BTIG Research lowered shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, The Goldman Sachs Group raised their price target on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research note on Monday, May 12th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $5.10.

Definitive Healthcare Stock Performance

The firm's 50-day moving average price is $3.58 and its two-hundred day moving average price is $3.64. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.75 and a current ratio of 1.75. The stock has a market cap of $582.67 million, a price-to-earnings ratio of -0.89, a PEG ratio of 7.04 and a beta of 1.64.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. The company had revenue of $59.19 million during the quarter, compared to analysts' expectations of $56.20 million. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. The firm's quarterly revenue was down 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.08 earnings per share. On average, analysts expect that Definitive Healthcare Corp. will post 0.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Quantbot Technologies LP boosted its position in Definitive Healthcare by 5,305.5% in the 4th quarter. Quantbot Technologies LP now owns 17,730 shares of the company's stock valued at $73,000 after buying an additional 17,402 shares during the period. Wells Fargo & Company MN increased its holdings in Definitive Healthcare by 27.4% during the 4th quarter. Wells Fargo & Company MN now owns 31,297 shares of the company's stock worth $129,000 after purchasing an additional 6,736 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in Definitive Healthcare by 20.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock worth $85,000 after purchasing an additional 3,496 shares during the period. Northern Trust Corp boosted its stake in shares of Definitive Healthcare by 3.2% in the 4th quarter. Northern Trust Corp now owns 497,279 shares of the company's stock valued at $2,044,000 after buying an additional 15,530 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Definitive Healthcare by 6.2% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company's stock worth $334,000 after buying an additional 4,748 shares in the last quarter. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.